Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03899077
Title Radiotherapy Combined With a LHRH (Ant)Agonist Versus Apalutamide in Patients With Biochemical Recurrence After RP (SAVE)
Acronym SAVE
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Cancer Research Antwerp
Age Groups: senior | adult
Covered Countries BEL

No variant requirements are available.